ArticleCureus2026
Severe Immune Thrombocytopenic Purpura Associated With Acute Epstein-Barr Virus Infection: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Immune thrombocytopenic purpura (ITP) is an autoimmune disorder characterized by immune-mediated platelet destruction. Viral infections, particularly Epstein-Barr virus (EBV), are recognized triggers of secondary ITP in children and young adults. Although EBV-associated ITP is often mild and self-limited, severe thrombocytopenia with clinically significant bleeding may occur. We report the case of an 18-year-old previously healthy woman who presented with severe thrombocytopenia associated with mucocutaneous bleeding, lymphadenopathy, and serological evidence of acute EBV infection. The patient was diagnosed with EBV-induced ITP and was successfully treated with systemic corticosteroids, achieving complete hematological and clinical recovery. This case highlights the importance of considering EBV infection in young patients presenting with acute severe thrombocytopenia and bleeding manifestations, as well as the generally favorable prognosis with appropriate management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.